O
LIVE

Serial Number

97718724

Owner

ProPharma Group Holdings, LLC

Attorney

Dianne M. Smith-Misemer

First Use Date

Jan 9, 2023

Filing Date

Dec 15, 2022

Add to watchlist:

No watchlists yet
View on USPTO

O Trademark

Serial Number: 97718724 • Registration: 7590238

O is a trademark filed by ProPharma Group Holdings, LLC on December 15, 2022. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

ProPharma Group Holdings, LLC

8717 W 110th Street, Suite 300
Overland Park, KS 66210

Entity Type: 16

Trademark Details

Filing Date

December 15, 2022

Registration Date

December 3, 2024

First Use Anywhere

January 9, 2023

First Use in Commerce

January 9, 2023

Published for Opposition

December 26, 2023

Goods & Services

Regulatory compliance consulting in the pharmaceutical, biotechnology, and medical fields; Regulatory compliance consulting in the fields of drug and device development and manufacturing; Tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for legal or regulatory compliance purposes; Tracking and monitoring regulatory requirements in the field of drug and device development and manufacturing for regulatory compliance purposes

Business information and business consulting services, namely, providing business advisory services to identify, screen, and select contract manufacturing organizations to contract and build medical and pharmaceutical products and devices; providing business advisory services to health care providers, namely, designing the administrative, financial and clinical workflows associated with value-based healthcare delivery models; providing business assistance to healthcare providers in the field of enabling communication and collaboration for the purpose of developing, implementing and evaluating patient care plans; Business services, namely, tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for business purposes; maintaining files and records concerning the medical condition of individuals; maintaining personal medical history records and files

Medical and pharmaceutical consultation; providing medical and pharmaceutical information services, namely, drug interaction call centers, adverse event reporting services for drugs and medical devices and product compliant reporting services for drugs and medical device; medical information; providing medical information, consultancy and advisory services; health care consulting, namely, aggregating clinical, claims, socioeconomic and behavioral health data for the purpose of improving healthcare providers' evaluation of health conditions and health risks with individual patients, cohorts of patients, and populations; health care consulting, namely, assessing patient and population health profiles using evidence-based medical guidelines for the purpose of improving healthcare provider treatment decisions at the point of care; providing information over a global computer network in the field of health care; providing medical information, consultancy, and advisory services, namely, providing healthcare providers, insurance companies, and healthcare product manufacturers with information and statistics regarding patient medication intake, schedule compliance, and health status

Providing quality assurance services in the medical, pharmaceutical, and biotechnology fields; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the medical, pharmaceutical, and biotechnology fields; Testing, analysis, and evaluation of medical, pharmaceutical, and biotechnology services to assure compliance with industry standards; Tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for quality control purposes; consulting services in the field of biotechnology

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 27, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 27, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 27, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 27, 2026 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 23, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 23, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 23, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 23, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 23, 2025 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 3, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 3, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 10, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 10, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 18, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 15, 2024 AITU
USE AMENDMENT FILED
Aug 12, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 12, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 20, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 26, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 26, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 6, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 21, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 16, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 16, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 16, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 21, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 21, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 21, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 19, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 13, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 12, 2023 NWOS
NEW APPLICATION ENTERED
Dec 19, 2022 NWAP